SafeHeal

[SafeHeal @safeheal]

What if patients could focus solely on their rectal cancer treatment, without the added stress of a temporary ostomy? 📷Our innovative Colovac® device, currently in the clinical investigation stage in the U.S., represents a potential shift in care — a less disruptive, less invasive alternative. We are committed to making this vision a reality for patients and potentially establishing this device as the new standard of care.

Be part of our journey. Follow SafeHeal® for more information and as well as a listing of our study sites in the US/EU.
https://t.co/9klXjcbWke

Colovac® is an investigational device limited by Federal (United States) law to investigational use. Colovac® is already approved for use in the EU.

[SafeHeal @safeheal]

What if patients could focus solely on their rectal cancer treatment, without the added stress of a temporary ostomy? 📷Our innovative Colovac® device, currently in the clinical investigation stage in the U.S., represents a potential shift in care — a less disruptive, less invasive alternative. We are committed to making this vision a reality for patients and potentially establishing this device as the new standard of care.
Be part of our journey. Follow SafeHeal® for more information and as well as a listing of our study sites in the US/EU.
https://t.co/9klXjccu9M
Colovac® is an investigational device limited by Federal (United States) law to investigational use. Colovac® is already approved for use in the EU.

[SafeHeal @safeheal]

What if patients could focus solely on their rectal cancer treatment, without the added stress of a temporary ostomy? 📷Our innovative Colovac® device, currently in the clinical investigation stage in the U.S., represents a potential shift in care — a less disruptive, less invasive alternative. We are committed to making this vision a reality for patients and potentially establishing this device as the new standard of care.
Be part of our journey. Follow SafeHeal® for more information and as well as a listing of our study sites in the US/EU.
https://t.co/9klXjcbWke
Colovac® is an investigational device limited by Federal (United States) law to investigational use. Colovac® is already approved for use in the EU.

[SafeHeal @safeheal]

What if patients could focus solely on their rectal cancer treatment, without the added stress of a temporary ostomy? 📷We are committed to making this vision a reality for patients and potentially establishing Colovac as the new standard of care. Be part of our journey.

Follow SafeHeal® for more information and as well as a listing of our clinical study sites in the US/EU. https://t.co/9klXjcbWke

Colovac® is an investigational device limited by Federal (United States) law to investigational use. Colovac® is already approved for use in the EU.

[SafeHeal @safeheal]

What if patients could focus solely on their rectal cancer treatment, without the added stress of a temporary ostomy?

📷Our innovative Colovac® device, currently in the clinical investigation stage in the U.S., represents a potential shift in care — a less disruptive, less invasive alternative. We are committed to making this vision a reality for patients and potentially establishing this device as the new standard of care. Be part of our journey. Follow SafeHeal® for more information and as well as a listing of our study sites in the US/EU. https://t.co/9klXjccu9M
Colovac® is an investigational device limited by Federal (United States) law to investigational use. Colovac® is already approved for use in the EU.

[SafeHeal @safeheal]

What if patients could focus solely on their rectal cancer treatment, without the added stress of a temporary ostomy?

📷Our innovative Colovac® device, currently in the clinical investigation stage in the U.S., represents a potential shift in care — a less disruptive, less invasive alternative. We are committed to making this vision a reality for patients and potentially establishing this device as the new standard of care. Be part of our journey. Follow SafeHeal® for more information and as well as a listing of our study sites in the US/EU. https://t.co/9klXjccu9M
Colovac® is an investigational device limited by Federal (United States) law to investigational use. Colovac® is already approved for use in the EU.

[SafeHeal @safeheal]

What if patients could focus solely on their rectal cancer treatment, without the added stress of a temporary ostomy?

📷Our innovative Colovac® device, currently in the clinical investigation stage in the U.S., represents a potential shift in care — a less disruptive, less invasive alternative. We are committed to making this vision a reality for patients and potentially establishing this device as the new standard of care. Be part of our journey. Follow SafeHeal® for more information and as well as a listing of our study sites in the US/EU. https://t.co/9klXjcbWke
Colovac® is an investigational device limited by Federal (United States) law to investigational use. Colovac® is already approved for use in the EU.

[SafeHeal @safeheal]

What if patients could focus solely on their rectal cancer treatment, without the added stress of a temporary ostomy?

📷Our innovative Colovac® device, currently in the clinical investigation stage in the U.S., represents a potential shift in care — a less disruptive, less invasive alternative. We are committed to making this vision a reality for patients and potentially establishing this device as the new standard of care. Be part of our journey. Follow SafeHeal® for more information and as well as a listing of our study sites in the US/EU. https://t.co/9klXjcbWke
Colovac® is an investigational device limited by Federal (United States) law to investigational use. Colovac® is already approved for use in the EU.

[SafeHeal @safeheal]

What if patients could focus solely on their rectal cancer treatment, without the added stress of a temporary ostomy?

📷Our innovative Colovac® device, currently in the clinical investigation stage in the U.S., represents a potential shift in care — a less disruptive, less invasive alternative. We are committed to making this vision a reality for patients and potentially establishing this device as the new standard of care.

Be part of our journey. Follow SafeHeal® for more information and as well as a listing of our study sites in the US/EU. https://t.co/9klXjcbWke

Colovac® is an investigational device limited by Federal (United States) law to investigational use. Colovac® is already approved for use in the EU.

[EU-Startups @EU_Startups]

#French #MedTech startup @safeheal, a medical device innovator transforming #colorectal surgery, today announced a €10 million extension of its oversubscribed €35 million #SeriesC financing round 🇫🇷 💉

https://t.co/iFUPAE0nTb

[SafeHeal @safeheal]

🎉 Exciting News! 🎉

SafeHeal® recently closed an oversubscribed €35 million Series C equity financing, led by Solar Eclipse with new investors Gideon Strategic Partners and M&L Healthcare (part of M&L Group), and continued support from Sofinnova Partners and a leading multinational life sciences corporation. This capital infusion leaves SafeHeal® well-funded to complete its IDE Pivotal study and accelerate preparation for the commercial launch of our lead technology, Colovac®.

A huge thank-you to our investors and the entire SafeHeal team for supporting our mission to drive innovation in colorectal surgery. 🙌

🔗 Read the full press release here: https://t.co/VDtTmakJoU

Colovac® is an Investigational Device, Limited by Federal (or United States) Law to Investigational Use.

#MedTech #ColorectalCancer #ColorectalCare #OstomyAlternatives #SafeHeal

[SafeHeal @safeheal]

We’re proud to announce the successful completion of enrollment in our Standard of Care (SH-SOC23) arm, the first phase of our two-part study in rectal cancer surgery! 🚀

🔜 Next Up: Once IDE approval is obtained, SafeHeal will initiate the SAFE-3CV study, which will evaluate the safety and effectiveness of Colovac®, our innovative endoluminal bypass device.

🙏 Thank you to our dedicated clinical investigators and the patients who participated. You’ve brought us one step closer to a future where patients may enjoy a better quality of life by reducing the burden of a temporary stoma and its associated complications and faster return to normal function.

Colovac is an Investigational Device, Limited by Federal (or United States) Law to Investigational Use

[SafeHeal @safeheal]

Currently enrolling at several sites throughout the US/ EU. Visit https://t.co/esM4lGpxQe to learn more about our study, sites and what we are doing to lessen the burden of #rectalcancer patients requiring a temporary ostomy.

[SafeHeal @safeheal]

Busy Month at Lankenau Hospital w/ Dr. John Marks! Dr. Marks enrolled 3 patients this month in the @safeheal SOC23 study which will provide robust Standard-of-Care Control data to which a future stoma alternative can be compared.

[SafeHeal @safeheal]

@pashtoonkasi @CCAlliance Great work @CCAlliance ! @safeheal is addressing the 'other' burden of RC patients: The 2-6 month diverting ostomy . We are currently enrolling patients in US/EU for our SOC trial. Visit https://t.co/esM4lGpxQe for sites and info.

[SafeHeal @safeheal]

@Chelsie_Sievers Thank you @Chelsie_Sievers! There is also the emotional and clinical impact of the temporary ostomy that many RC patients also face. @safeheal is addressing this issue. Enrolling patients now in US/EU. Visit https://t.co/yWalQDMPtJ for info and sites. Please repost if possible!

[SafeHeal @safeheal]

@SoniaRamMD @ASCRS_1 @CMSSmed @safeheal is addressing the burden of a Temporary Diverting Ostomy for patients who must undergo #RectalCancer surgery. Our study has over 20 active sites (US/EU) currently enrolling with more before the end of the year. visit https://t.co/yWalQDMPtJ

[SafeHeal @safeheal]

@FightCRC @count_me_in @KimmieNgMD @JJSingleton1 @FightCRC @KimmieNgMD and @JJSingleton1. @safeheal is researching the Temporary Ostomy aspect of #rectalcancer. Our SOC trial enrolling and seeking patients. Visit https://t.co/esM4lGp00G for sites and info and please repost this if you can!

[SafeHeal @safeheal]

Awesome @FightCRC ! @safeheal is addressing the other burden many RC patients must face after LAR surgery-Temporary ostomy. We are currently enrolling in our SOC trail and seek patients in the US/EU. https://t.co/gpTH0khhrK for sites/info. Please repost if possible. Thank You